News

There are many reasons you might want coffee alternatives. You may want to avoid the jitters or gastrointestinal effects of ...
From bold new flavors to timeless classics, if you're looking for the best-tasting teas, these expert-guided picks should be ...
Millions drink coffee daily, but it may have health effects. Learn how to make your coffee healthier by avoiding these common ...
Herbal supplements may come with side effects and interact negatively with certain medications. You should always consult your healthcare professional before adding supplements to your routine.
And, for what it’s worth, there is some data to suggest yerba mate may be associated with losing weight: It stimulates ...
Asthma is a chronic lung disease caused by an immune response. However, it is not considered an autoimmune disease. Asthma is inflammation of the airways that carry air to and from the lungs.
The Ayush drug licensing authority in Kerala warned Pankajakasthuri Herbals India Pvt Ltd for publishing a misleading ad without approval, violating Rule 170. Rule 170 requires state licensing ...
a CD20-directed bispecific antibody currently being evaluated in a Phase 1 trial in B-cell non-Hodgkin lymphoma patients and is expanding into various autoimmune indications. The drug candidate ...
Sanofi said it would acquire Bispecific Myeloid Cell Engager, an autoimmune disease treatment, from Dren Bio, for up to $1.9 billion. The French pharmaceutical company on Thursday said it would ...
The Dren Bio therapy is part of a growing trend of research into autoimmune disease medicines that can reset the immune system instead of suppressing it. The work is built on promising results in ...
Houman Ashrafian, head of research and development at Sanofi, said in a statement that this approach of inducing deep B cell depletion “is at the forefront of treating autoimmune diseases” and has ...
A phase 3 trial of Immunovant’s FcRn inhibitor batoclimab has hit its primary endpoint. But, having made a second-generation molecule its lead candidate last year, the biotech isn’t currently ...